These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1590697)
21. Biodegradable functional polycarbonate micelles for controlled release of amphotericin B. Wang Y; Ke X; Voo ZX; Yap SSL; Yang C; Gao S; Liu S; Venkataraman S; Obuobi SAO; Khara JS; Yang YY; Ee PLR Acta Biomater; 2016 Dec; 46():211-220. PubMed ID: 27686042 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and toxicity evaluation of new amphotericin B micelle systems for brain fungal infections. Moreno-Rodríguez AC; Torrado-Durán S; Molero G; García-Rodríguez JJ; Torrado-Santiago S Int J Pharm; 2015 Oct; 494(1):17-22. PubMed ID: 26256151 [TBL] [Abstract][Full Text] [Related]
23. In-vitro and in-vivo evaluation of a new amphotericin B emulsion-based delivery system. Tabosa Do Egito ES; Appel M; Fessi H; Barratt G; Puisieux F; Devissaguet JP J Antimicrob Chemother; 1996 Sep; 38(3):485-97. PubMed ID: 8889723 [TBL] [Abstract][Full Text] [Related]
24. Efficacies of amphotericin B-desoxycholate (Fungizone), liposomal amphotericin B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. van Etten EW; van den Heuvel-de Groot C; Bakker-Woudenberg IA J Antimicrob Chemother; 1993 Nov; 32(5):723-39. PubMed ID: 8125837 [TBL] [Abstract][Full Text] [Related]
25. [In vitro effect of amphotericin B on polymorphonuclear chemotaxis and large granular lymphocytes with natural killer activity]. Bernaudin F; Hathorn J; Schaufele R; Pizzo PA Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1403-7. PubMed ID: 3325905 [TBL] [Abstract][Full Text] [Related]
26. Comparison of antifungal activity of amphotericin B deoxycholate suspension with that of amphotericin B cholesteryl sulfate colloidal dispersion. Hanson LH; Stevens DA Antimicrob Agents Chemother; 1992 Feb; 36(2):486-8. PubMed ID: 1605618 [TBL] [Abstract][Full Text] [Related]
27. Analysis of choline and phosphorylcholine content in human neutrophils stimulated by f-Met-Leu-Phe and phorbol myristate acetate: contribution of phospholipase D and C. Pédruzzi E; Hakim J; Giroud JP; Périanin A Cell Signal; 1998 Jul; 10(7):481-9. PubMed ID: 9754716 [TBL] [Abstract][Full Text] [Related]
28. Neutrophil caveolin-1 expression contributes to mechanism of lung inflammation and injury. Hu G; Ye RD; Dinauer MC; Malik AB; Minshall RD Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L178-86. PubMed ID: 17993589 [TBL] [Abstract][Full Text] [Related]
29. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections. Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480 [TBL] [Abstract][Full Text] [Related]
30. Self-assembled amphotericin B-loaded polyglutamic acid nanoparticles: preparation, characterization and in vitro potential against Candida albicans. Zia Q; Khan AA; Swaleha Z; Owais M Int J Nanomedicine; 2015; 10():1769-90. PubMed ID: 25784804 [TBL] [Abstract][Full Text] [Related]
31. Comparative study of the efficacy of liposomal amphotericin B and amphotericin B deoxycholate against six species of Zygomycetes in a murine lethal infection model. Takemoto K; Yamamoto Y; Kanazawa K J Infect Chemother; 2010 Dec; 16(6):388-95. PubMed ID: 20535522 [TBL] [Abstract][Full Text] [Related]
32. GM-CSF primes and modulates neonatal PMN motility: up-regulation of C3bi (Mo1) expression with alteration in PMN adherence and aggregation. Cairo MS; VandeVen C; Toy C; Suen Y; Mauss D; Sender L Am J Pediatr Hematol Oncol; 1991; 13(3):249-57. PubMed ID: 1838903 [TBL] [Abstract][Full Text] [Related]
33. New pharmacological studies with pentoxifylline. Novick WJ; Sullivan G; Mandell G Biorheology; 1990; 27(3-4):449-54. PubMed ID: 2261511 [TBL] [Abstract][Full Text] [Related]
34. Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. Mansfield PJ; Hinkovska-Galcheva V; Carey SS; Shayman JA; Boxer LA Blood; 2002 Feb; 99(4):1434-41. PubMed ID: 11830497 [TBL] [Abstract][Full Text] [Related]
35. Liposomal amphotericin B (AmBisome) compared with amphotericin B +/- FMLP induces significantly less in vitro neutrophil aggregation with granulocyte-colony-stimulating factor/dexamethasone-mobilized allogeneic donor neutrophils. Sulis ML; Van de Ven C; Henderson T; Anderson L; Cairo MS Blood; 2002 Jan; 99(1):384-6. PubMed ID: 11756198 [TBL] [Abstract][Full Text] [Related]
36. Novel biodegradable poly(gamma-glutamic acid)-amphotericin B complexes show promise as improved amphotericin B formulations. Dinh T; Zia Q; Zubair S; Stapleton P; Singh R; Owais M; Somavarapu S Nanomedicine; 2017 Jul; 13(5):1773-1783. PubMed ID: 28216150 [TBL] [Abstract][Full Text] [Related]
37. Postinjury neutrophil priming and activation: an early vulnerable window. Botha AJ; Moore FA; Moore EE; Kim FJ; Banerjee A; Peterson VM Surgery; 1995 Aug; 118(2):358-64; discussion 364-5. PubMed ID: 7638753 [TBL] [Abstract][Full Text] [Related]
38. Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans. van Etten EW; Chander HR; Snijders SV; Bakker-Woudenberg IA J Antimicrob Chemother; 1995 Dec; 36(6):961-74. PubMed ID: 8821595 [TBL] [Abstract][Full Text] [Related]
39. N-acetylcysteine and ambroxol inhibit endotoxin-induced phagocyte accumulation in rat lungs. Nawrocka A; Papierz W; Bialasiewicz P; Stolarek R; Komos J; Nowak D Pulm Pharmacol Ther; 1999; 12(6):369-75. PubMed ID: 10587478 [TBL] [Abstract][Full Text] [Related]